https://www.selleckchem.com/pr....oducts/Dexamethasone
mechanisms, including downregulation of CDKN1A and its p21 protein product this in turn is mediated through direct binding of ETV4 to the CDKN1A promoter and through the ETV4-mediated decrease of p53. This multi-faceted role of ETV4 in prostate cancer makes it a potential target for novel therapeutic approaches that could be explored in this ETV4 transgenic model. Mutations in CRYAA, which encodes the α-crystallin protein, are associated with a spectrum of congenital cataract-microcornea syndromes. In this study, we performed clin
Aimer
Commentaire
Partagez
